4.6 Article

Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates

期刊

CHEMISTRY-A EUROPEAN JOURNAL
卷 24, 期 47, 页码 12250-12253

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/chem.201800872

关键词

albumin; anticancer drug; drug delivery; gold(I) complex; targeted therapeutics

资金

  1. EU [ED481B 2014/086-0]
  2. FCT Portugal (FCT Investigator)
  3. EPSRC
  4. EPSRC [EP/M003647/1] Funding Source: UKRI

向作者/读者索取更多资源

Targeted delivery of potent cytotoxic drugs to cancer cells minimizes systemic toxicity and several side effects. NHC*-Au-Cl has already been proven to be a potent anticancer agent. In this study, we explore a strategy based on chemoselective cysteine conjugation of NHC*-Au-Cl to albumin and trastuzumab (Thiomab LC-V205C) to potentiate drug-ligand ratio, pharmacokinetics, as well as drug efficacy and safety. This strategy is a step forward towards the use of gold-based anticancer agents as targeted therapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin

Marco Mellado, Cesar Gonzalez, Jaime Mella, Luis F. Aguilar, Ismail Celik, Fernanda Borges, Eugenio Uriarte, Giovanna Delogu, Dolores Vina, Maria J. Matos

Summary: Monoamine oxidases (MAOs) have been identified as attractive targets in drug design due to their role in modulating neurotransmitter levels and reactive oxygen species production. In this study, a comparative analysis was conducted to evaluate the inhibitory activity of two coumarin-based compounds (3-phenylcoumarin and trans-6-styrylcoumarin) on both MAO isoforms. Crystallographic structures, 3D-QSAR models, docking simulations, and molecular dynamics simulations were utilized to investigate the interaction mechanisms between these compounds and MAOs. Trans-6-styrylcoumarin exhibited significantly higher inhibitory activity on MAO-B compared to 3-phenylcoumarin and trans-resveratrol.

MOLECULES (2022)

Editorial Material Chemistry, Medicinal

Treating neurodegenerative diseases with multitarget drugs: an interview with Maria Joao Matos

Maria Joao Matos

Summary: Neurodegenerative diseases are a major cause of death, disability and dependency worldwide. Current therapeutic options only provide temporary relief of symptoms. Research on multitarget compounds for Alzheimer's and Parkinson's diseases offers potential therapeutic approaches.

FUTURE MEDICINAL CHEMISTRY (2022)

Article Chemistry, Multidisciplinary

Synthesis and study of the trypanocidal activity of catechol-containing 3-arylcoumarins, inclusion in β-cyclodextrin complexes and combination with benznidazole

Josue Pozo-Martinez, Francisco Salgado, Ana Liempi, Ulrike Kemmerling, Raul Mera-Adasme, Claudio Olea-Azar, Mauricio Moncada-Basualto, Fernanda Borges, Eugenio Uriarte, Maria Joao Matos

Summary: The study demonstrated that a series of catechol-containing 3-arylcoumarins have moderate trypanocidal activity on the trypomastigote form of the parasite, with 3-(4'-bromophenyl)-6,7-dihydroxycoumarin (8) showing the highest activity but also the highest cytotoxicity in Vero cells. The inclusion in beta-cyclodextrins reduced the trypanocidal activity and cytotoxicity, but increased solubility. Compound 8 was found to act through the generation of oxidative stress, and the combination with BZN showed a synergistic effect, reducing the necessary dose of BZN and proving to be a promising alternative strategy for treating the disease.

ARABIAN JOURNAL OF CHEMISTRY (2022)

Article Chemistry, Medicinal

Structural Insight of New Butyrylcholinesterase Inhibitors Based on Benzylbenzofuran Scaffold

Giovanna L. Delogu, Antonella Fais, Francesca Pintus, Chinmayi Goyal, Maria J. Matos, Benedetta Era, Amit Kumar

Summary: In this study, a combination of computational and biochemical techniques was used to modify the structure of benzofuran derivatives and identify relevant structural features for butyrylcholinesterase inhibitory activity and selectivity. By introducing a methylene spacer and substituents, a novel selective BChE inhibitor was discovered. 5-bromo-2-(4-hydroxybenzyl)benzofuran 9B exhibited the strongest inhibitory activity. Computational studies confirmed the correlation between the theoretical and experimental binding affinity of the compounds to the BChE protein.

PHARMACEUTICALS (2022)

Review Biochemistry & Molecular Biology

Thiocoumarins: From the Synthesis to the Biological Applications

Maria J. Matos, Lourdes Santana, Eugenio Uriarte, Fernanda Borges

Summary: This article provides a review of the synthesis and biological applications of thiocoumarins and their derivatives. It emphasizes their potential as drug candidates and highlights the research progress in the past 5 years. The information presented is based on data collected from multiple electronic databases.

MOLECULES (2022)

Editorial Material Chemistry, Medicinal

Medicinal Chemistry in Portugal and Spain: A Strong Iberian Alliance

Maria Joao Matos, Maria-Jesus Blanco

ACS MEDICINAL CHEMISTRY LETTERS (2022)

Article Chemistry, Medicinal

Synthesis and Vasorelaxant Activity of Nitrate-Coumarin Derivatives

Maria Joao Matos, Eugenio Uriarte, Nuria Seoane, Aitor Picos, Jose Gil-Longo, Manuel Campos-Toimil

Summary: The newly synthesized nitrate-coumarins have been found to possess vasorelaxant activity on rat aorta rings, making them potential alternatives for the development of vasodilator drugs.

CHEMMEDCHEM (2022)

Article Toxicology

Cytogenotoxicity assessment of 3-(3,4-dihydroxyphenyl)-7,8-dihydroxycoumarin on HepG2/C3A cells and leukocytes

Ana Paula Martins Castanha, Laiza Moura Almeida-Terassi, Estela Guardado-Yordi, Maria Joao Matos, Edson Luis Maistro

Summary: This study explored the safety and genotoxicity of a newly synthesized coumarin derivative, and found that the compound exhibited no cytotoxicity and protected cells from DNA damage at tested concentrations.

JOURNAL OF APPLIED TOXICOLOGY (2023)

Article Biochemistry & Molecular Biology

Hydroxy-3-Phenylcoumarins as Multitarget Compounds for Skin Aging Diseases: Synthesis, Molecular Docking and Tyrosinase, Elastase, Collagenase and Hyaluronidase Inhibition, and Sun Protection Factor

Francesca Pintus, Sonia Floris, Antonella Fais, Benedetta Era, Amit Kumar, Gianluca Gatto, Eugenio Uriarte, Maria Joao Matos

Summary: This study investigates the inhibitory activity of certain compounds on enzymes involved in skin aging, such as tyrosinase, elastase, collagenase, and hyaluronidase. Several compounds were found to inhibit these enzymes, with five compounds acting as dual inhibitors. Compounds 1 and 2 showed the most promising anti-aging activity and also demonstrated a photo-protective effect.

MOLECULES (2022)

Article Chemistry, Medicinal

8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin?s antidepressant profile: Synthesis, biological evaluation and docking studies

Maria J. Matos, Paula Novo, Lucia Mayan, Iria Torres, Eugenio Uriarte, Matilde Yanez, Jose Angel Fontenla, Francesco Ortuso, Stefano Alcaro, Francesca Procopio, Maria Isabel Rodriguez-Franco, Cristina Val, Maria I. Loza, Jose Brea, Fernanda Borges, Dolores Vina

Summary: Psychiatric and neurological disorders affect millions of people worldwide, and current treatments are limited in their effectiveness. New therapeutic solutions are urgently needed to improve the lives of patients.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies

David Cabezas, Guido Mellado, Nicolas Espinoza, Jose Antonio Garate, Cesar Morales, Alejandro Castro-Alvarez, Maria J. Matos, Marco Mellado, Jaime Mella

Summary: Glycogen synthase kinase 3 (GSK-3) plays a role in various diseases and inhibiting GSK-3 could have pro-insulin effects. Aminopyrimidine derivatives have already proven to be promising GSK-3 inhibitors. In this study, CoMFA and CoMSIA models were developed to design new compounds with antidiabetic activity.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Review Chemistry, Medicinal

Recent Advances in Biologically Active Coumarins from Marine Sources: Synthesis and Evaluation

Laura Fernandez-Pena, Maria Joao Matos, Enol Lopez

Summary: Coumarin and its derivatives are of great interest to medicinal chemists and chemical biologists due to their wide range of biological and pharmacological properties. Interesting families of coumarins have been discovered from marine sources, which have significantly accelerated the drug discovery process through inspiring innovation and identification of analogues with remarkable biological properties. This review aims to showcase the most interesting marine-derived coumarins from a medicinal chemistry perspective, as well as the novel and useful synthetic routes described to achieve these chemical structures. The references for this overview were collected from PubMed, Mendeley, and SciFinder.

MARINE DRUGS (2023)

Article Chemistry, Medicinal

Oxidation-labile linkers for controlled drug delivery

Aitor Carneiro, Lourdes Santana, Maria Joao Matos

Summary: The continuous symbiosis between chemical biology and drug discovery has led to the design of innovative bifunctional molecules for targeted and controlled drug delivery. Protein-drug and peptide-drug conjugates are popular approaches to achieve targeted delivery, selectivity, and efficacy. The selection of appropriate payloads and linkers is crucial for meeting the main goals of these bioconjugates, particularly in neurodegenerative diseases and certain cancer types where oxidative stress plays an important role. This mini-review covers the most relevant publications on oxidation-labile linkers.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2023)

Article Chemistry, Medicinal

Design of 3-Phenylcoumarins and 3-Thienylcoumarins as Potent Xanthine Oxidase Inhibitors: Synthesis, Biological Evaluation, and Docking Studies

Antonella Fais, Francesca Pintus, Benedetta Era, Sonia Floris, Amit Kumar, Debapriyo Sarmadhikari, Valeria Sogos, Eugenio Uriarte, Shailendra Asthana, Maria Joao Matos

Summary: The coumarin scaffold shows promise in the development of bioactive agents, and this study focuses on the synthesis and evaluation of hydroxylated 3-arylcoumarins for their XO inhibition and antioxidant properties. Compound 11 is found to be the most potent XO inhibitor, and both compounds 11 and 5 show mixed-type inhibition and good antioxidant activity. Molecular docking studies correlate the theoretical and experimental binding affinity to the XO binding pocket.

CHEMMEDCHEM (2023)

Review Chemistry, Medicinal

Propargylamine: an important moiety in drug discovery

Aitor Carneiro, Eugenio Uriarte, Fernanda Borges, Maria Joao Matos

Summary: Propargylamine is widely used in medicinal chemistry and chemical biology due to its unique reactivity. This review discusses the applications and potential of propargylamine-based compounds in drug discovery, highlighting their impact in various therapeutic fields.

FUTURE MEDICINAL CHEMISTRY (2023)

暂无数据